XML 112 R52.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Notes to the consolidated financial statements - Research and development (R&D) expenses (Details) - Operative Expenses [Member] - EUR (€)
€ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Notes to the Consolidated Statements of Operations      
Materials € (78,767) € (121,873) € (278,542)
Personnel (113,422) (99,924) (94,655)
Amortization and depreciation (27,229) (26,641) (17,232)
Patents and fees to register a legal right (6,666) (3,813) (3,199)
Third-party services (67,905) (39,501) (708,636)
Maintenance and lease (15,356) (9,381) (7,528)
Other (8,170) (17,064) (14,415)
Total (335,760) (353,539) (1,156,247)
Research and development expenses      
Notes to the Consolidated Statements of Operations      
Materials (19,126) (32,982) (232,292)
Personnel (43,267) (33,944) (33,733)
Amortization and depreciation (8,539) (8,650) (4,259)
Patents and fees to register a legal right (6,666) (3,813) (3,199)
Third-party services (28,587) 20,499 (539,786)
Maintenance and lease (7,287) (1,069) (347)
Other (2,252) (2,591) (2,291)
Total (115,724) € (62,550) € (815,907)
Reversal of provision for onerous contracts 38,533    
Estimated contract termination provisions € 25,059